These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 29170026)

  • 1. Nose-to-brain peptide delivery - The potential of nanotechnology.
    Samaridou E; Alonso MJ
    Bioorg Med Chem; 2018 Jun; 26(10):2888-2905. PubMed ID: 29170026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.
    Kulkarni AD; Vanjari YH; Sancheti KH; Belgamwar VS; Surana SJ; Pardeshi CV
    J Drug Target; 2015; 23(9):775-88. PubMed ID: 25758751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using nanotechnology to deliver biomolecules from nose to brain - peptides, proteins, monoclonal antibodies and RNA.
    Borrajo ML; Alonso MJ
    Drug Deliv Transl Res; 2022 Apr; 12(4):862-880. PubMed ID: 34731414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery.
    Singh D; Dubey P; Pradhan M; Singh MR
    Expert Opin Drug Deliv; 2013 Feb; 10(2):241-59. PubMed ID: 23265137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides.
    Qian S; Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1491-508. PubMed ID: 25196358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nose to brain delivery in rats: Effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization.
    Bonaccorso A; Musumeci T; Serapide MF; Pellitteri R; Uchegbu IF; Puglisi G
    Colloids Surf B Biointerfaces; 2017 Jun; 154():297-306. PubMed ID: 28363190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral peptide delivery: challenges and the way ahead.
    Dubey SK; Parab S; Dabholkar N; Agrawal M; Singhvi G; Alexander A; Bapat RA; Kesharwani P
    Drug Discov Today; 2021 Apr; 26(4):931-950. PubMed ID: 33444788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.
    Ong WY; Shalini SM; Costantino L
    Curr Med Chem; 2014; 21(37):4247-56. PubMed ID: 25039773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
    Selvaraj K; Gowthamarajan K; Karri VVSR
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Nanotechnology in Delivery of Protein and Peptide Drugs.
    Patil S; Vhora I; Amrutiya J; Lalani R; Misra A
    Curr Pharm Des; 2015; 21(29):4155-73. PubMed ID: 26323432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for Effective Brain Drug Delivery.
    Comoglu T; Arisoy S; Akkus ZB
    Curr Top Med Chem; 2017; 17(13):1490-1506. PubMed ID: 28017157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs.
    Griffin BT; Guo J; Presas E; Donovan MD; Alonso MJ; O'Driscoll CM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):367-380. PubMed ID: 27320644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal drug delivery for brain targeting.
    Vyas TK; Shahiwala A; Marathe S; Misra A
    Curr Drug Deliv; 2005 Apr; 2(2):165-75. PubMed ID: 16305417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.